INDIVIOR PHARMACEUTICALS INC (INDV) Stock Fundamental Analysis
NASDAQ:INDV • US45579U1097
34.75 USD
+0.17 (+0.49%)
At close: Feb 17, 2026
34.61 USD
-0.14 (-0.4%)
Pre-Market: 2/18/2026, 4:24:17 AM
INDV gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. INDV has an excellent profitability rating, but there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on INDV.
1. Profitability
1.1 Basic Checks
- INDV had positive earnings in the past year.
- INDV had a positive operating cash flow in the past year.
- In multiple years INDV reported negative net income over the last 5 years.
- The reported operating cash flow has been mixed in the past 5 years: INDV reported negative operating cash flow in multiple years.
1.2 Ratios
- With an excellent Return On Assets value of 8.62%, INDV belongs to the best of the industry, outperforming 89.53% of the companies in the same industry.
- With an excellent Return On Invested Capital value of 50.62%, INDV belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for INDV is significantly above the industry average of 12.64%.
- The last Return On Invested Capital (50.62%) for INDV is above the 3 year average (43.06%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.62% | ||
| ROE | N/A | ||
| ROIC | 50.62% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
1.3 Margins
- Looking at the Profit Margin, with a value of 10.34%, INDV belongs to the top of the industry, outperforming 84.29% of the companies in the same industry.
- In the last couple of years the Profit Margin of INDV has declined.
- With an excellent Operating Margin value of 24.49%, INDV belongs to the best of the industry, outperforming 91.62% of the companies in the same industry.
- In the last couple of years the Operating Margin of INDV has remained more or less at the same level.
- Looking at the Gross Margin, with a value of 85.51%, INDV belongs to the top of the industry, outperforming 88.48% of the companies in the same industry.
- INDV's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.49% | ||
| PM (TTM) | 10.34% | ||
| GM | 85.51% |
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
2. Health
2.1 Basic Checks
- INDV has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- The number of shares outstanding for INDV has been reduced compared to 1 year ago.
- The number of shares outstanding for INDV has been reduced compared to 5 years ago.
- The debt/assets ratio for INDV is higher compared to a year ago.
2.2 Solvency
- INDV has an Altman-Z score of 2.73. This is not the best score and indicates that INDV is in the grey zone with still only limited risk for bankruptcy at the moment.
- INDV has a Altman-Z score of 2.73. This is in the better half of the industry: INDV outperforms 67.02% of its industry peers.
- INDV has a debt to FCF ratio of 2.68. This is a good value and a sign of high solvency as INDV would need 2.68 years to pay back of all of its debts.
- With an excellent Debt to FCF ratio value of 2.68, INDV belongs to the best of the industry, outperforming 92.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.68 | ||
| Altman-Z | 2.73 |
ROIC/WACC5.36
WACC9.45%
2.3 Liquidity
- A Current Ratio of 0.96 indicates that INDV may have some problems paying its short term obligations.
- INDV's Current ratio of 0.96 is on the low side compared to the rest of the industry. INDV is outperformed by 86.39% of its industry peers.
- INDV has a Quick Ratio of 0.96. This is a bad value and indicates that INDV is not financially healthy enough and could expect problems in meeting its short term obligations.
- INDV's Quick ratio of 0.79 is on the low side compared to the rest of the industry. INDV is outperformed by 82.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 256.36% over the past year.
- INDV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -53.19% yearly.
- The Revenue has decreased by -0.25% in the past year.
- INDV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.64% yearly.
EPS 1Y (TTM)256.36%
EPS 3Y-75.32%
EPS 5Y-53.19%
EPS Q2Q%33.33%
Revenue 1Y (TTM)-0.25%
Revenue growth 3Y14.52%
Revenue growth 5Y8.64%
Sales Q2Q%2.28%
3.2 Future
- The Earnings Per Share is expected to grow by 37.61% on average over the next years. This is a very strong growth
- Based on estimates for the next years, INDV will show a small growth in Revenue. The Revenue will grow by 1.36% on average per year.
EPS Next Y440.8%
EPS Next 2Y161.63%
EPS Next 3Y95.81%
EPS Next 5Y37.61%
Revenue Next Year3.67%
Revenue Next 2Y-0.17%
Revenue Next 3Y1.6%
Revenue Next 5Y1.36%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 17.73, which indicates a rather expensive current valuation of INDV.
- Compared to the rest of the industry, the Price/Earnings ratio of INDV indicates a rather cheap valuation: INDV is cheaper than 86.39% of the companies listed in the same industry.
- INDV's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.16.
- The Price/Forward Earnings ratio is 11.54, which indicates a very decent valuation of INDV.
- Based on the Price/Forward Earnings ratio, INDV is valued cheaper than 87.43% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of INDV to the average of the S&P500 Index (28.10), we can say INDV is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.73 | ||
| Fwd PE | 11.54 |
4.2 Price Multiples
- INDV's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. INDV is cheaper than 84.29% of the companies in the same industry.
- 80.10% of the companies in the same industry are more expensive than INDV, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.15 | ||
| EV/EBITDA | 13.38 |
4.3 Compensation for Growth
- INDV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of INDV may justify a higher PE ratio.
- INDV's earnings are expected to grow with 95.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y161.63%
EPS Next 3Y95.81%
5. Dividend
5.1 Amount
- INDV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
34.75
+0.17 (+0.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-26 2026-02-26/amc
Inst Owners92.33%
Inst Owner Change-0.83%
Ins Owners3.78%
Ins Owner Change31.01%
Market Cap4.34B
Revenue(TTM)1.18B
Net Income(TTM)122.00M
Analysts84.62
Price Target46.48 (33.76%)
Short Float %10.17%
Short Ratio5.01
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)81.89%
Min EPS beat(2)71.47%
Max EPS beat(2)92.31%
EPS beat(4)4
Avg EPS beat(4)70.49%
Min EPS beat(4)45.92%
Max EPS beat(4)92.31%
EPS beat(8)6
Avg EPS beat(8)12.14%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)19.31%
Min Revenue beat(2)17.53%
Max Revenue beat(2)21.1%
Revenue beat(4)4
Avg Revenue beat(4)14.97%
Min Revenue beat(4)8.6%
Max Revenue beat(4)21.1%
Revenue beat(8)5
Avg Revenue beat(8)7.48%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)20.38%
PT rev (3m)212.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.43%
EPS NY rev (3m)79.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)12.81%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.73 | ||
| Fwd PE | 11.54 | ||
| P/S | 3.68 | ||
| P/FCF | 36.15 | ||
| P/OCF | 24.1 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.38 |
EPS(TTM)1.96
EY5.64%
EPS(NY)3.01
Fwd EY8.67%
FCF(TTM)0.96
FCFY2.77%
OCF(TTM)1.44
OCFY4.15%
SpS9.45
BVpS-1.66
TBVpS-1.67
PEG (NY)0.04
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.62% | ||
| ROE | N/A | ||
| ROCE | 64.08% | ||
| ROIC | 50.62% | ||
| ROICexc | 3805.17% | ||
| ROICexgc | 5707.75% | ||
| OM | 24.49% | ||
| PM (TTM) | 10.34% | ||
| GM | 85.51% | ||
| FCFM | 10.17% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)54.5%
ROCE(5y)38.6%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
F-Score8
Asset Turnover0.83
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.68 | ||
| Debt/EBITDA | 0.97 | ||
| Cap/Depr | 230.77% | ||
| Cap/Sales | 5.08% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 57.14% | ||
| Profit Quality | 98.36% | ||
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 2.73 |
F-Score8
WACC9.45%
ROIC/WACC5.36
Cap/Depr(3y)163.83%
Cap/Depr(5y)132.28%
Cap/Sales(3y)2.67%
Cap/Sales(5y)2.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)256.36%
EPS 3Y-75.32%
EPS 5Y-53.19%
EPS Q2Q%33.33%
EPS Next Y440.8%
EPS Next 2Y161.63%
EPS Next 3Y95.81%
EPS Next 5Y37.61%
Revenue 1Y (TTM)-0.25%
Revenue growth 3Y14.52%
Revenue growth 5Y8.64%
Sales Q2Q%2.28%
Revenue Next Year3.67%
Revenue Next 2Y-0.17%
Revenue Next 3Y1.6%
Revenue Next 5Y1.36%
EBIT growth 1Y8.24%
EBIT growth 3Y11.69%
EBIT growth 5Y7.28%
EBIT Next Year1050.98%
EBIT Next 3Y148.27%
EBIT Next 5Y64.69%
FCF growth 1Y236.36%
FCF growth 3Y-74.97%
FCF growth 5Y-48.94%
OCF growth 1Y446.15%
OCF growth 3Y-53.28%
OCF growth 5Y-24.93%
INDIVIOR PHARMACEUTICALS INC / INDV FAQ
What is the fundamental rating for INDV stock?
ChartMill assigns a fundamental rating of 5 / 10 to INDV.
What is the valuation status of INDIVIOR PHARMACEUTICALS INC (INDV) stock?
ChartMill assigns a valuation rating of 8 / 10 to INDIVIOR PHARMACEUTICALS INC (INDV). This can be considered as Undervalued.
What is the profitability of INDV stock?
INDIVIOR PHARMACEUTICALS INC (INDV) has a profitability rating of 7 / 10.
How financially healthy is INDIVIOR PHARMACEUTICALS INC?
The financial health rating of INDIVIOR PHARMACEUTICALS INC (INDV) is 4 / 10.
Is the dividend of INDIVIOR PHARMACEUTICALS INC sustainable?
The dividend rating of INDIVIOR PHARMACEUTICALS INC (INDV) is 0 / 10 and the dividend payout ratio is 0%.